[Federal Register Volume 77, Number 61 (Thursday, March 29, 2012)]
[Notices]
[Page 19005]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-7489]
=======================================================================
-----------------------------------------------------------------------
CONSUMER PRODUCT SAFETY COMMISSION
Notice of Teleconference of the Chronic Hazard Advisory Panel on
Phthalates and Phthalate Substitutes
AGENCY: Consumer Product Safety Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The Consumer Product Safety Commission (``CPSC'' or
``Commission'') is announcing a teleconference and the seventh meeting
of the Chronic Hazard Advisory Panel (CHAP) on phthalates and phthalate
substitutes. The Commission appointed this CHAP on April 14, 2010, to
study the effects on children's health of all phthalates and phthalate
alternatives, as used in children's toys and child care articles,
pursuant to section 108 of the Consumer Product Safety Improvement Act
of 2008 (CPSIA) (Pub. L. 110-314). The CHAP will discuss its progress
toward completing its analysis of potential risks from phthalates and
phthalate substitutes.
DATES: The teleconference will take place from 11 a.m. to 1 p.m. EDT
(15:00 to 17:00 GMT) on Tuesday, April 10, 2012. Interested members of
the public may listen to the CHAP's discussion. Members of the public
will not have the opportunity to ask questions, comment, or otherwise
participate in the teleconference. Interested parties should contact
the CPSC project manager, Michael Babich, by email (mbabich@cpsc.gov),
for call-in instructions no later than Friday, April 6, 2012.
FOR FURTHER INFORMATION CONTACT: Michael Babich, Directorate for Health
Sciences, Consumer Product Safety Commission, Bethesda, MD 20814;
telephone (301) 504-7253; email: mbabich@cpsc.gov.
SUPPLEMENTARY INFORMATION: Section 108 of the CPSIA permanently
prohibits the sale of any ``children's toy or child care article''
containing more than 0.1 percent of each of three specified phthalates:
Di- (2-ethylhexyl) phthalate (DEHP), dibutyl phthalate (DBP), and
benzyl butyl phthalate (BBP). Section 108 of the CPSIA also prohibits,
on an interim basis, the sale of any ``children's toy that can be
placed in a child's mouth'' or ``child care article'' containing more
than 0.1 percent of each of three additional phthalates: Diisononyl
phthalate (DINP), diisodecyl phthalate (DIDP), and di-n-octyl phthalate
(DnOP).
Moreover, section 108 of the CPSIA requires the Commission to
convene a CHAP ``to study the effects on children's health of all
phthalates and phthalate alternatives as used in children's toys and
child care articles.'' The CPSIA requires the CHAP to complete an
examination of the full range of phthalates that are used in products
for children and:
Examine all of the potential health effects (including
endocrine-disrupting effects) of the full range of phthalates;
Consider the potential health effects of each of these
phthalates, both in isolation, and in combination with other
phthalates;
Examine the likely levels of children's, pregnant women's,
and others' exposure to phthalates, based upon a reasonable estimation
of normal and foreseeable use and abuse of such products;
Consider the cumulative effect of total exposure to
phthalates, both from children's products and from other sources, such
as personal care products;
Review all relevant data, including the most recent, best-
available, peer-reviewed, scientific studies of these phthalates and
phthalate alternatives that employ objective data-collection practices
or employ other objective methods;
Consider the health effects of phthalates not only from
ingestion, but also as a result of dermal, hand-to-mouth, or other
exposure;
Consider the level at which there is a reasonable
certainty of no harm to children, pregnant women, or other susceptible
individuals and their offspring, considering the best available
science, and using sufficient safety factors to account for
uncertainties regarding exposure and susceptibility of children,
pregnant women, and other potentially susceptible individuals; and
Consider possible similar health effects of phthalate
alternatives used in children's toys and child care articles.
The CPSIA contemplates completion of the CHAP's examination within
18 months of the panel's appointment on April 14, 2010. The CHAP has an
additional 6 months to complete its final report to the Commission. The
CHAP must review prior work on phthalates by the Commission, but it is
not to be considered determinative because the CHAP's examination must
be conducted de novo.
The CHAP must make recommendations to the Commission regarding any
phthalates (or combinations of phthalates), in addition to those
identified in section 108 of the CPSIA, or phthalate alternatives that
the panel determines should be prohibited from use in children's toys
or child care articles, or otherwise restricted. The CHAP members were
selected by the Commission from scientists nominated by the National
Academy of Sciences. See 15 U.S.C. 2077, 2030(b).
The CHAP met previously in April, July, and December 2010, March,
July, and November 2011, and in February 2012, at the CPSC's offices in
Bethesda, MD, and by teleconference in November 2010, September 2011,
December 2011, and February 2012. The CHAP heard testimony from
interested parties at the July 2010, and November 2011, meetings. There
will not be any opportunity for public comment during the April 2012
teleconference.
Dated: March 23, 2012.
Alberta E. Mills,
Acting Secretary, Consumer Product Safety Commission.
[FR Doc. 2012-7489 Filed 3-28-12; 8:45 am]
BILLING CODE 6355-01-P